Enable Biosciences Inc. has been awarded a National Institutes of Health/National Institute of Allergy and Infectious Diseases Small Business Innovation Research Phase I grant for $223,806 to accelerate development of its minimally invasive, ultrasensitive, and specific blood tests for food allergy.